Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.AI Announces Increase in Revenue Growth for Arway with Map D Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News AstraZeneca ADR Representing 0.5 Ord Shs AZN

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex... see more

Current News (NDAQ:AZN)

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

Business Wire 5 days ago

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers

Business Wire 12 days ago

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Business Wire March 1, 2025

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

Business Wire February 26, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit - AZN

ACCESS Newswire February 21, 2025

AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN

ACCESS Newswire February 21, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN

ACCESS Newswire February 21, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Business Wire February 21, 2025

Levi & Korsinsky Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZN

ACCESS Newswire February 21, 2025
View More News ››

Opinion & Analysis (NDAQ:AZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AZN)

AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript

News; $AZN AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript2024-07-25 11:45:11 ET Image source: The Motley Fool. AstraZeneca Plc...
whytestocks - July 25, 2024

Datopotamab Deruxtecan Biologics License Application Accepte

Just In: $AZN Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced...
whytestocks - February 19, 2024

AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

Breaking News: $AZN AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript2024-02-08 16:15:30 ET Image source: The Motley Fool...
whytestocks - February 8, 2024

Hospital Infection Therapeutics Market Size & Share 2021-26

According to IMARC Group’s latest report, titled “Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth...
edwardebreen15 - August 22, 2022

Aztra vaccine coming to Canada soon news?

https://www.msn.com/en-ca/news/newspolitics/health-canada-to-decide-on-astrazeneca-covid-19-vaccine-in-coming-days/ar-BB1ddoDT?ocid...
Rejean1 - January 29, 2021

Conflicting news???

I thought I just read elsewhere they had banned shots to people over 65? A month after it received approval in the UK, the EU’s...
Rejean1 - January 29, 2021
View more Bullboard ››

Spod Lithium Corp.

Spod Lithium Corp.

Spod Lithium Corp. is a Canada-based exploration and development company focused on unlocking the potential of lithium ...
View More »